4Life recently underwent a Full Scope Dietary Supplement Inspection by the Food and Drug Administration (FDA) and received the best possible result of “no deficiencies or warnings.” The inspection required a four-day, intensive onsite review of the company’s 100,000 square-foot Warehousing, Manufacturing and Packaging operation.
“Full Scope means that the FDA Investigator inspected us against the entire Dietary Supplement manufacturing regulation 21 CFR 111—which includes Personnel, Plant and Grounds, Production and Process Control System, Requirements for Quality Control, Laboratory Operations, Complaints and Returns, and Recordkeeping,” said Steve Pederson, 4Life Senior Vice President, Quality. “The FDA Investigator detailed our physical plant, equipment and sanitation…as well as hundreds of Standard Operation Procedures, logs, documents and records. 4Life customers can rest assured: 4Life Transfer Factor products are unparalleled.”
The company stated that it is “uncommon” to go through a full scope inspection with zero observed deficiencies, and says the FDA attributed this result to the brand’s commitment to quality, general preparedness and compliance in all areas.
“Our executive leadership team allocates significant resources for 4Life’s quality systems and laboratories,” Pederson said. “I could not be prouder of our team—whose primary objective is to provide best-in-class immune system supplementation at every level, from farm and field to encapsulation and bottling.”
